Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis

Background: Current ulcerative colitis (UC) treatments are focused on symptom management primarily via immune suppression. Despite the current arsenal of immunosuppressant treatments, the majority of patients with UC still experience disease progression. Importantly, aggressive long-term inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Sham, Ho Pan, Bazett, Mark, Bosiljcic, Momir, Yang, Hyungjun, Luk, Beryl, Law, Hong T., Morampudi, Vijay, Yu, Hong B., Pankovich, Jim, Sutcliffe, Simon, Bressler, Brian, Marshall, John K., Fedorak, Richard N., Chen, Jenny, Jones, Michelle, Gunn, Hal, Kalyan, Shirin, Vallance, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170651/
https://www.ncbi.nlm.nih.gov/pubmed/30319652
http://dx.doi.org/10.3389/fimmu.2018.02211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170651/
https://www.ncbi.nlm.nih.gov/pubmed/30319652
http://dx.doi.org/10.3389/fimmu.2018.02211

Ejemplares similares